Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
“taking bookings of SEK 41 million in this quarter. This more than doubled the order book of the whole of 2022 from SEK 32 million to SEK 73 million at the end of Q1….. At mid May the order backlog stands at SEK 91.5 million.”
https://wyldnetworks.com/directus/assets/ac46217e-e174-4b33-86a5-68c59b97f4f5
Katstrangler, Musk for fun and his ego splashed $46 billions on Twitter which has no relevance to his businesses. Wyld tech is a must for his SpaceX. Why wouldn’t he throw few $10s millions at Wyld to take it over rather be hostage to others’ fortunes?
Also Go read Wyld Q1 result, income more than double vs the whole of the year 2022…and by May 2023 it nearly tripled, results of Q2 due this month should be very interesting indeed. Yet before that we should hear developments with SpaceX, and maybe even a tweet from Musk as he likes being on the limelight. What did his tweet on doge coin do to its price, 12000% (???) in few days lol?
Musk likes to be in the limelight using his tweets. Expect his tweet in the form “we will soon provide internet connectivity in the most remote areas on the planet eg “Africa”, since he’s African. What did his tweet on doge coin do to the price? 10-12000%+? Can recall really
“View from Vox
The news today builds on the announcement in June that Philips' MR 7700 MRI scanner was to be combined with XENOVIEW technology, showcasing the capability to enhance pulmonary imaging. Polarean's collaboration with a major industry player marks a significant milestone, demonstrating the wide applicability of Polarean's technology and positioning the company for increased visibility and recognition within the medical imaging market.
Polarean’s XENOVIEW 3.0T Chest Coil was cleared by the FDA in December 2022.
It’s estimated that almost 550 million people worldwide are living with chronic lung disease, demonstrating the huge demand for medical imaging to aid in early diagnosis. Providing an enhanced picture of the lungs may help a variety of patients suffering from lung diseases, which can include idiopathic pulmonary fibrosis, COPD, pulmonary hypertension, radiation therapy, cystic fibrosis and asthma.
Polarean remains well-funded, with $16.5m in the bank at the end of 2022, positioning it well to continue advancing XENOVIEW across various stages of commercialisation in the US and beyond.”
https://www.voxmarkets.co.uk/articles/polarean-receives-fda-clearance-supporting-collaboration-with-philips--3546285
No logical explanation for 21% fall in the sp, really. Even if news of placing was leaked, no reason why this would command 20% discount, considering the recent news of Philips, no to mention FDA. imo it’s a big forced seller with commitment elsewhere. It should recover quickly helped with today rns.
I like the fact that Ohara says he’s pleased with the recent sp rise yet it still has to go up further “to reflect true value”. And goes on to justify this with the excellent progress made so far, suggesting deals in the pipelines to be announced with large companies in hot sectors and the launch of Amazon Germany, Amazon India and Amazon USA soon.
….which bodes well for Opti, suggesting opportunities for either tie up, takeover by cos in the sector or Opti successfully going it alone.
https://hbw.pharmaintelligence.informa.com/RS153878/Nestl-Invests-In-Microbiome-Research-As-VMS-Sales-Stumble
No way this staggering increases over the last few days is due to trading. More like a company building a stake, not even IIs. If one considers the 11 big cos interested in Opti products
Dano71, Fum sp is performing very well in comparison to most shares. The markets have been going down for over 2 years and since 2019 if include covid. Once sales figures are released (which could be anytime, it doesn’t have to quarterly update) which are expected to staggering from the comment of Fum marketing partner, then the sp will motor for sometime, imo.
Impressive rns yet MMs take it down. Only one explanation: scaring people into selling for IIs. Watch them taking it up much higher this afternoon which they’ve doing all this week and some of last week, start red finish blue. Todays rns justifies stronger blue than usual, 2 days ago finished 11% and yesterday 6%